Valuation and M&A assistance for the scale-up QUALIblood, a Belgian CRO specialized in blood analysis
02 August 2022
In the context of a contemplated fundraising by QUALIblood, BDO has conducted a valuation analysis as well as drafted an information memorandum to the attention of potential investors.
QUALIblood is a Belgian CRO aiming at providing pharmaceutical industry, hospitals and universities with tailor-made support and biomedical research. The company is specialized in blood and biomarker analyses, samples storage, hemocompatibility testing, as well as clinical studies.
For the valuation part of the assignment, BDO prepared a business plan with the management of QUALIblood.
The info memo summarized key market, business and financial information, necessary for further M&A steps.